Tag: IBRO
CHEST: Nerandomilast Slows Decline in FVC in Idiopathic Pulmonary Fibrosis
No significant difference seen in composite end point of acute exacerbation, hospitalization for respiratory cause, or death
FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis
Twice-daily oral tablet marks first approval of idiopathic pulmonary fibrosis in more than 10 years
Prevalence of Alcohol-Related Liver Fibrosis More Than Doubled Over Last 20 Years
1999-2004 to 2013-2020 saw increase in prevalence of high FIB-4 from 1.8 to 4.3 percent, despite no increase in alcohol use
Myocardial Fibrosis Linked to Ventricular Arrhythmia in Male Endurance Athletes
Myocardial fibrosis remained predictive after adjusting for left ventricular end-diastolic volume indexed
Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis
Waist-to-height ratio outperforms body mass index-indicated obesity
Dapagliflozin Beneficial for Improving MASH Without Worsening Fibrosis
Dapagliflozin results in more patients with improved or resolved MASH without worsening of fibrosis, improved fibrosis without worsening of MASH
